Trial Profile
Left Ventricular Hypertrophy Reduction With Statins in Hypertensive Patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2010
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Simvastatin (Primary) ; Valsartan (Primary) ; Pravastatin
- Indications Hypercholesterolaemia; Hypertension; Left ventricular hypertrophy
- Focus Therapeutic Use
- Acronyms REVIERTE
- Sponsors Merck & Co
- 06 Mar 2008 New trial record.